Screener
Regenxbio RGNX Contract Liabilities, Non-Current
Contract Liabilities, Non-Current at other companies
Other financials
Where this comes from
Reported directly by Regenxbio in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.
The source filing: Regenxbio’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:15 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336725
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Operating lease liabilities | 7,355 | 8,286 |
| Royalty monetization liabilities | 26,765 | 39,609 |
| Total current liabilities | 82,621 | 118,095 |
| Deferred revenue | 15,404 | 18,943 |
| Operating lease liabilities | 61,596 | 65,215 |
| Royalty monetization liabilities | 154,746 | 147,408 |
| Other liabilities | 486 | 638 |
| Total liabilities | 314,853 | 350,299 |
Item 1. Financial Statements.
FAQ
- What is Regenxbio's contract liabilities, non-current?
- Regenxbio (RGNX) reported contract liabilities, non-current of $15.4M in Q2 2026.
- How has Regenxbio's contract liabilities, non-current changed year-over-year?
- Regenxbio's contract liabilities, non-current decreased by 35.3% year-over-year, from $23.8M to $15.4M.
- What does contract liabilities, non-current mean?
- Obligation to transfer goods or services for which payment has been received, expected to be satisfied beyond one year.
Ask your AI about Regenxbio's contract liabilities, non-current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude